This episode was recorded on Monday, March 30, 2020.
Claim credit here: https://ce.mayo.edu/covid19podcast
Guest: Matthew P. Van Cuyk, Pharm.D., R.Ph.
Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)
Should we be using ibuprofen to treat patients with COVID-19? Does this fall into the modifiable risk category? Dr. Matthew Van Cuyk breaks down recent events and literature around ibuprofen use in patients with COVID-19.
- Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. March 2020. https://doi.org/10.1016/S2213-2600(20)30116-8
- HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
- ASHP Coronavirus Resource Center: https://www.ashp.org/Pharmacy-Practice/Resource-Centers/Coronavirus
- Assessment of Evidence for COVID-19-Related Treatments: Updated 3/27/2020
For the most up to date COVID-19 information: